Mycophenolic acid upregulates MIR-142-3P/5P and MIR-146a in lupus CD4+T cells

Lupus

Volumn 24, Issue 9, 2015, Pages 935-942

  Tang, Q ^a   Yang, Y ^a   Zhao, M ^a   Liang, G ^a   Wu, H ^a   Liu, Q ^a   Xie, Y ^b   Li, D ^a   Dai, Y ^c   Yung, S ^d   Chan, T M ^d   Lu, Q ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Changsha Blood Center   (China)

^c JINAN UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD4+T cells; microRNAs; mycophenolic acid; Systemic lupus erythematosus

Indexed keywords

DEXAMETHASONE; INOSINATE DEHYDROGENASE; METHOTREXATE; MICRORNA; MICRORNA 142 3P 5P; MICRORNA 146A; MYCOPHENOLIC ACID; UNCLASSIFIED DRUG; CD40 LIGAND; IMPDH1 PROTEIN, HUMAN; MIRN142 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN;

ACETYLATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HISTONE MODIFICATION; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; PROMOTER REGION; RNA EXTRACTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THERAPY EFFECT; UPREGULATION; ADOLESCENT; ADULT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CASE CONTROL STUDY; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMP DEHYDROGENASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; MYCOPHENOLIC ACID; UP-REGULATION; YOUNG ADULT;

EID: 84929354495     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315570685     Document Type: Article

References (25)

1. Tsokos GC,. Systemic lupus erythematosus. N Engl J Med 2011; 365: 2110-2121.
2. Hewagama A, Richardson B,. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11.
3. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q,. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 2013; 41: 92-99.
4. Jonsson CA, Carlsten H,. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages. Cell Immunol 2002; 216: 93-101.
5. Iaccarino L, Rampudda M, Canova M, Della LS, Sarzi-Puttinic P, Doria A,. Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 2007; 6: 190-195.
6. Liu LL, Jiang Y, Wang LN, Yao L, Li ZL,. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: A meta-analysis of randomized controlled trials. Drugs 2012; 72: 1521-1533.
7. Dooley MA, Jayne D, Ginzler EM,. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011; 365: 1886-1895.
8. Su DL, Wang HJ, Ji XH,. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Acta Pharmacol Sin 2006; 27: 1051-1057.
9. Bartel DP,. MicroRNAs: Genomics biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
10. Kang SG, Liu WH, Lu P,. MicroRNAs of the miR-17 approximately 92 family are critical regulators of T(FH) differentiation. Nat Immunol 2013; 14: 849-857.
11. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD,. MicroRNAs: New regulators of immune cell development and function. Nat Immunol 2008; 9: 839-845.
12. Li QJ, Chau J, Ebert PJ,. MiR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-161.
13. Ceribelli A, Yao B, Dominguez-Gutierrez PR, Nahid MA, Satoh M, Chan EK,. MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 2011; 13: 229.
14. Zhao S, Wang Y, Liang Y,. MicroRNA-126 regulates DNA methylation in CD4 + T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011; 63: 1376-1386.
15. Tang Y, Luo X, Cui H,. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-1075.
16. Zhou Q, Haupt S, Prots I,. MiR-142-3p is involved in CD25 + CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J Immunol 2013; 190: 6579-6588.
17. Lu X, Li X, He Q,. MiR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates. Cell Res 2013; 23: 1356-1368.
18. Sun W, Shen W, Yang S, Hu F, Li H, Zhu TH,. MiR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res 2010; 20: 1158-1169.
19. Ding S, Liang Y, Zhao M,. Decreased microRNA-142-3p/5p expression causes CD4 + T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2953-2963.
20. Yang L, Boldin MP, Yu Y,. MiR-146a controls the resolution of T cell responses in mice. J Exp Med 2012; 209: 1655-1670.
21. Tan EM, Cohen AS, Fries JF,. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
22. Zhao M, Liu Q, Liang G,. E4BP4 overexpression: A protective mechanism in CD4 + T cells from SLE patients. J Autoimmun 2013; 41: 152-160.
23. Crispin JC, Kyttaris VC, Terhorst C, Tsokos GC,. T cells as therapeutic targets in SLE. Nat Rev Rheumatol 2010; 6: 317-325.
24. Boldin MP, Taganov KD, Rao DS,. MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208: 1189-1201.
25. Van den Hove DL, Kompotis K, Lardenoije R,. Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol Aging 2014; 35: 731-745.